Research
Revolution Drug Doubles Pancreatic Cancer Survival
Revolution Medicine's experimental pancreatic cancer drug daraxonrasib has shown remarkable results by doubling survival time compared to standard chemotherapy. According to multiple reports from Reuters, The Guardian, Sky News, CBS News, PBS, Daily Mail and StatNews the once-daily pill significantl
May 31, 9:19 AM ET·2 min read
8 articles from 7 publishers